Liwu Fu Selected Research

Liwu Fu Research Topics

Disease

59	Neoplasms (Cancer) 03/2022 - 04/2004
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 09/2015
5	Lung Neoplasms (Lung Cancer) 01/2021 - 08/2015
5	Breast Neoplasms (Breast Cancer) 09/2017 - 11/2010
3	Carcinogenesis 01/2022 - 01/2019
3	Esophageal Squamous Cell Carcinoma 01/2018 - 06/2014
3	Leukemia 01/2018 - 01/2016
3	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2010
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 05/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Papillary Thyroid Cancer 01/2020
1	Adenocarcinoma 01/2019
1	Type 2 Diabetes Mellitus (MODY) 11/2017
1	Acute Promyelocytic Leukemia 09/2017
1	Hepatocellular Carcinoma (Hepatoma) 08/2017
1	Retinoblastoma (Glioblastoma, Retinal) 01/2017
1	Circulating Neoplastic Cells 01/2017
1	Malignant Mesothelioma 01/2017

Drug/Important Bio-Agent (IBA)

13	Adenosine Triphosphate (ATP)IBA 05/2020 - 01/2014
12	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2019 - 01/2014
11	Pharmaceutical PreparationsIBA 01/2022 - 01/2013
10	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2010
7	Tyrosine Kinase InhibitorsIBA 05/2020 - 09/2015
6	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2019 - 11/2010
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2013
4	Immune Checkpoint InhibitorsIBA 10/2021 - 01/2020
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 09/2015
3	Oncogene Proteins (Oncogene Protein)IBA 01/2022 - 04/2016
3	multidrug resistance-associated protein 1IBA 09/2017 - 11/2010
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2013 - 11/2010
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022 - 05/2019
2	B7-H1 AntigenIBA 01/2021 - 01/2020
2	osimertinibIBA 01/2021 - 01/2016
2	Conditioned Culture MediaIBA 01/2021 - 01/2010
2	Antineoplastic Agents (Antineoplastics)IBA 06/2020 - 01/2014
2	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2019
2	Drug CombinationsIBA 01/2020 - 01/2018
2	CalciumIBA 01/2019 - 01/2018
2	ceritinibIBA 01/2018 - 12/2015
2	Anaplastic Lymphoma KinaseIBA 01/2017 - 12/2015
2	Adenosine Triphosphatases (ATPase)IBA 01/2017 - 08/2015
2	Antiviral Agents (Antivirals)IBA 02/2016 - 10/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2015 - 10/2012
2	Topotecan (Hycamtin)FDA LinkGeneric 08/2015 - 01/2015
1	lazertinibIBA 03/2022
1	F-Box ProteinsIBA 01/2022
1	mirdametinibIBA 10/2021
1	Small Interfering RNA (siRNA)IBA 10/2021
1	ClathrinIBA 01/2021
1	Aldehyde DehydrogenaseIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	rho-Associated KinasesIBA 06/2020
1	rociletinibIBA 05/2020
1	vorolanibIBA 03/2020
1	bcr-abl Fusion ProteinsIBA 01/2020
1	UbiquitinIBA 01/2020
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2020
1	AntibodiesIBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2020
1	Ligases (Synthetase)IBA 01/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	Circular RNAIBA 01/2020
1	Granzymes (Granzyme)IBA 01/2020
1	Glucose Transporter Type 2IBA 01/2020
1	VimentinIBA 01/2020
1	CTLA-4 AntigenIBA 01/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2020
1	Member 2 Subfamily G ATP Binding Cassette TransporterIBA 05/2019
1	secalonic acidIBA 05/2019
1	mitochondrial calcium uniporterIBA 01/2019
1	Mediator ComplexIBA 01/2019
1	conglobatinIBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2018
1	Carcinoembryonic AntigenIBA 12/2018
1	Proteolysis Targeting ChimeraIBA 10/2018
1	olmutinibIBA 07/2018
1	dacomitinibIBA 02/2018
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2018
1	NF-kappa B (NF-kB)IBA 01/2018
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	RP4010IBA 01/2018
1	Peptides (Polypeptides)IBA 11/2017
1	Glucose (Dextrose)FDA LinkGeneric 11/2017
1	Arsenic Trioxide (Trisenox)FDA Link 09/2017
1	abemaciclibIBA 01/2017
1	AfatinibIBA 01/2017
1	Biological ProductsIBA 01/2017
1	AsbestosIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2017
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2017
1	alectinibIBA 01/2017

Therapy/Procedure

21	Drug Therapy (Chemotherapy) 05/2020 - 04/2004
17	Therapeutics 01/2022 - 01/2010
3	Radiotherapy 01/2020 - 08/2015
2	Immunotherapy 10/2021 - 01/2021
2	Combination Drug Therapy (Combination Chemotherapy) 12/2015 - 12/2015
1	Precision Medicine 01/2021